Burden of cardio-renal-metabolic conditions in adults with type 2 diabetes within the Diabetes Collaborative Registry

Diabetes, Obesity and Metabolism

Volumn 20, Issue 8, 2018, Pages 2000-2003

  Arnold, Suzanne V ^a   Kosiborod, Mikhail ^a   Wang, Jingyan ^a   Fenici, Peter ^b   Gannedahl, Goran ^c   LoCasale, Robert J ^b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

cardiometabolic; cardiovascular disease; diabetes mellitus

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE BURDEN; DISEASE REGISTRY; FEMALE; GOUT; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT ISOLATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION DISTRIBUTION; PREVALENCE; RISK FACTOR; SEX RATIO; TOBACCO USE; VERY ELDERLY; AGE; COMPLICATION; COST OF ILLNESS; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; INTERDISCIPLINARY COMMUNICATION; METABOLIC SYNDROME X; REGISTER; RISK; SEX FACTOR; UNITED STATES; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; METABOLIC SYNDROME; MIDDLE AGED; PREVALENCE; REGISTRIES; RISK; SEX FACTORS; TOBACCO USE; UNITED STATES; YOUNG ADULT;

EID: 85045710718     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.13303     Document Type: Article

References (12)

1. Suh DC, Choi IS, Plauschinat C, Kwon J, Baron M. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004. J Diabetes Complications. 2010;24:382-391.
2. Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383:1899-1911.
3. Palsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21:273-280.
4. Rifkind BM. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Am J Cardiol. 1984;54:30C-34C.
5. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140-149.
6. Arnold SV, Inzucchi SE, McGuire DK, et al. Evaluating the quality of comprehensive cardiometabolic care for patients with type 2 diabetes in the U.S.: the Diabetes Collaborative Registry. Diabetes Care. 2016;39:e99-e101.
7. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: U.S. Department of Health and Human Services http://www.diabetes.org/assets/pdfs/basics/cdc-statistics-report-2017.pdf. Accessed February 28, 2018.
8. Goodman LA. On simultaneous confidence intervals for multinomial proportions. Technometrics. 1965;7:247-254.
9. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269-2276.
10. Akalin S, Berntorp K, Ceriello A, et al. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. Int J Clin Pract. 2009;63:1421-1425.
11. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554-559.
12. American Diabetes Association. Standards of Medical Care in Diabetes-2017: summary of revisions. Diabetes Care. 2017;40:S4-S5.